Singapore National Eye Centre

For your convenience, you may also consult with the SNEC ophthalmologists (eye-doctors) at the following branches and affiliated centres listed. Eye surgery is also performed at Sengkang General Hospital, Changi General Hospital and KK Women’s & Children’s Hospital (for children) by the SNEC ophthalmologists. Please discuss with our Appointments Dept (for consultation) or Listing Room Staff (for surgery).

DrZainah Corp Video
new SNEC building
SERI banner
Education corporate banner

Giving ＆ Philanthropy

Established in 2016, VisionSave exists to save sight and transform the lives of the underprivileged population with vision challenges. Our approach leverages philanthropic investments to pave the way for a holistic delivery of eye care.

SingVision

In this special anniversary edition of SingVision, we’re shining a light on the people and milestones that made it all possible, from progress across our 10 clinical interests, and advances in education, training, and research, to nurse-led treatments, global collaborations, and heartfelt wishes from our staff and patients.

SNEC Branches & Affiliated Clinics

You can now also consult with SNEC ophthalmologists at our satellite branches and affiliated centres. Our specialists also perform eye surgeries at Sengkang General Hospital and Changi General Hospital, Please contact our Appointment Department for consultations or speak with our Listing Room staff for surgery scheduling.

Our Commitment to Our Patients

Our Featured Specialties

Cataract & Comprehensive Ophthalmology

Corneal & External Eye Disease

Glaucoma

Medical Retina

Neuro-ophthalmology

Ocular Inflammation & Immunology

Oculoplastic

Paediatric Ophthalmology & Adult Strabismus

Refractive Surgery

Surgical Retina

Latest News

Research Formosa Pharmaceuticals and SERI Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases SINGAPORE / TAIPEI — April 30, 2026 – Formosa Pharmaceuticals, Inc. (“Formosa”, 6838.TW) and the Singapore Eye Research Institute (“SERI”) are pleased to announce a strategic research collaboration to develop next-generation ophthalmic formulations. This partnership will leverage Formosa’s proprietary APNT® (Active Pharmaceutical (ingredient) Nanoparticle Technology) and SERI’s world-class clinical research expertise, led by renowned Clinician Scientist, Associate Professor Yu-Chi Liu, MD, PhD. The collaboration aims to address significant unmet needs in the treatment of corneal and ocular surface diseases. By combining innovative and clinically validated drug delivery platforms with deep clinical insights, the joint effort seeks to enhance the efficacy, bioavailability, and safety of topical ocular therapies, bringing new therapies to clinical practice. Synergy of Innovation and Clinical Excellence A/Prof Yu-Chi Liu, clinician scientist at Singapore National Eye Center and Principal Investigator at SERI, brings extensive experience in corneal neuropathy and translational medicine to the collaboration. Her recent work in diabetic keratopathy and ocular surface inflammation will be pivotal in guiding the development of formulations targeting complex anterior segment conditions. "Collaborating with Formosa Pharmaceuticals allows us to bridge the gap between benchside innovation and bedside application," said A/Prof. Yu-Chi Liu. "Our goal is to utilize advanced formulation technologies like APNT to create treatments that are not only more effective but also less burdensome for patients suffering from ocular conditions." Leveraging APNT® Technology Formosa Pharmaceuticals’ APNT® platform specializes in reducing the particle size of active pharmaceutical ingredients (APIs) to stable, uniform nanoparticles. This technology is a hallmark of Formosa's development pipeline, offering a powerful solution for improving the delivery of poorly soluble drugs to the target tissues and organs. "We are honored to work alongside Professor Liu and her distinguished team at SERI," said Erick Co, President & CEO of Formosa Pharmaceuticals. "Initial efforts have confirmed compatibility of APNT and SERI’s research models and prompt us to extend our partnership. SERI’s reputation for excellence in vision research, backed by their comprehensive capabilities and facilities, are unparalleled. Together, we are excited to translate the research findings into better clinical outcomes."

30 Apr 2026 Read Story

Education Singapore National Eye Centre and Singapore Polytechnic collaborate to strengthen optometrists’ role in community eye care The partnership will see both parties co-develop the Clinical Decision-Making in Community Optometry training programme for practicing community optometrists to build on their competencies to deliver quality eye care in the community.

05 Mar 2026 Read Story

Announcements Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the same field among all institutes, globally.

28 Jan 2026 Read Story

View all news

Upcoming Events

View All

Singapore National Eye Centre, Global Eye Ophthalmology Unit is a designated WHO Collaborating Centre for the prevention of blindness and vision impairment.